THE STATE OF HUMORAL IMMUNITY TO MEASLES, RUBELLA AND MUMPS IN HEALTHY PEOPLE AND PATIENTS WITH MEASLES



Cite item

Full Text

Abstract

Abstract

Measles, rubella and mumps are viral infections that can be prevented with highly effective vaccines. Recently, the incidence of measles and mumps has increased in many countries, involving highly immunized populations. The aim of the study was to assess measles, rubella and mumps humoral immunity in healthy people of different ages and compare these data with measles incidence in same area during the same time period. The serum samples from 713 conditionally healthy residents of different ages from Moscow and the Moscow region with an unknown vaccination history and from 700 patients with measles collected on the 4th-5th day after onset of rash were examined. Humoral immunity was determined by ELISA using the kits from AO Vector-Best, Russian Federation and Euroimmun, Germany. It was found that in the group of 1–5-year-old subjects, the seropositivity rate was below 60%. Seroprevalence in groups over 6-year-old subjects against rubella fluctuates at the level of 87-94%, mumps - 72-83%. The most unstable situation was observed in humoral immunity against measles virus. In the group of 6-13-year-old subjects, seroprevalence increased to 79% followed by decline to 49.5% in group of 18-30-year-old subjects. The subsequent increase in seropositivity to 88.12% in the group over 51-year-old subjects was significantly lower than the calculated population immunity level (95%). Among measles patients in 2024, children and adolescents accounted for 54.32%. Comparison of measles incidence with the measles seronegative level in the same age groups revealed a clear pattern: the more seronegative were subjects, the higher measles incidence was in this group. In a similar study on measles incidence in 2013, all children and adolescents responded to the infection with a primary immune response, and among adult patients, a secondary immune response was detected in 12-18%. In 2024, among children and adolescents with measles, 9-12% responded with a secondary immune response, and in adult groups, the proportion of secondary response reached 44%, indicating that individuals vaccinated in childhood but who lost measles antibodies during life actively contribute to measles cases. Vaccination of seronegative grades 10-11 adolescents is necessary.

About the authors

Polina E. Zherdeva

G.N.Gabrichevsky Research Institute for Epidemiology and Microbiology, Moscow, Russia

Email: polya-zherdeva@mail.ru
SPIN-code: 1675-7056

Researcher of applied immunochemistry laboratory

Россия, 125212, Moscow, Admiral Makarov str., 10

Anna P. Toptygina

G.N.Gabrichevsky Research Institute for Epidemiology and Microbiology, Moscow, Russia;
Lomonosov Moscow State University

Email: toptyginaanna@rambler.ru
ORCID iD: 0000-0002-9981-4762
Scopus Author ID: 6602424818
ResearcherId: В-6725-2019

DSc (Medicine), Head Researcher, Head of the Laboratory of Cytokines, Professor, Department of Faculty of Biology

Россия, 125212, Moscow, Admiral Makarov str., 10; 119991 Moscow, Leninskiye Gory, 1

Anna V. Nozdracheva

Gamaleya National Research Center of Epidemiology and Microbiology, of the Ministry of Health of the Russian Federation

Email: nozdracheva@gamaleya.org
SPIN-code: 3631-8083

PhD (Medicine), Head of Laboratory of nonspecific prophylaxis of infection diseases

Россия, 18, Gamaieya str. 123098 Moscow, Russia

Tamara A. Mamaeva

G.N.Gabrichevsky Research Institute for Epidemiology and Microbiology, Moscow, Russia

Email: 4522826@bk.ru
SPIN-code: 2037-1553

PhD (Biology), Leading Research of applied immunochemistry laboratory

Россия, 125212, Moscow, Admiral Makarov str., 10

Lidia I. Novikova

G.N.Gabrichevsky Research Institute for Epidemiology and Microbiology, Moscow, Russia

Email: novikovalida414@gmail.com
SPIN-code: 9507-7419

PhD (Medicine), Head of the Laboratory of immunobiological preparations

Россия, 125212, Moscow, Admiral Makarov str., 10

Marina A. Smerdova

JSC Vector-Best-Europe, Russia

Email: biologsmerdova@yandex.ru
SPIN-code: 3070-7065

PhD (Biology), Leading Product Specialist 

Россия, Moscow, Sosenskoye settlement, Nikolo-Khovanskoye village, house 1011B

Maria S. Iаrmolskaia

FGUZ Center for Hygiene and Epidemiology in Moscow

Email: poliolab@yandex.ru

Head of the Virology Department of the Microbiological Laboratory

Россия, 129626, Moscow, Grafsky lane, 4 bldg. 2,3,4

Natalia G. Dementeva

FGUZ Center for Hygiene and Epidemiology in Moscow

Email: poliolab@yandex.ru

Virologist, Department of Virology, Microbiological Laboratory

Россия, 129626, Moscow, Grafsky lane, 4 bldg. 2,3,4

Tat'yana P. Gotvyanskay

Gamaleya National Research Center of Epidemiology and Microbiology, of the Ministry of Health of the Russian Federation

Email: gotvin@gamaleya.org
ORCID iD: 0000-0002-0814-2666
SPIN-code: 9288-2300

PhD (Biology), Senior Researcher, Laboratory of nonspecific prophylaxis of infection diseases, Department of Epidemiology

Россия, 18, Gamaieya str. 123098 Moscow, Russia

Anatoliy V. Semenenko

Gamaleya National Research Center of Epidemiology and Microbiology, of the Ministry of Health of the Russian Federation

Author for correspondence.
Email: centronix@gmail.com
SPIN-code: 2944-0376

PhD (Engineering), Senior Researcher, Laboratory of nonspecific prophylaxis of infection diseases, Department of Epidemiology

Россия, 18, Gamaieya str. 123098 Moscow, Russia

References

  1. Бичурина М.А., Филипович-Вигньевич С.Б., Антипова А.Ю., Банцевич М.Д., Лаврентьева И.Н. Популяционный иммунитет к вирусам кори и краснухи у населения Республики Сербия // Инфекция и иммунитет. 2021. Т. 11, № 1. С. 171–176. Bichurina M.A., Filipović-Vignjević S., Antipova A.Yu., Bančević M., Lavrentieva I.N. A herd immunity to measles and rubella viruses in the population of the Republic of Serbia // Russian Journal of Infection and Immunity = Infektsiya i immunitet, 2021, vol. 11, no. 1, pp. 171–176. (In Russ.) doi: 10.15789/2220-7619-TTO-1496
  2. Готвянская Т.П., Ноздрачева А.В., Русакова Е.В., Евсеева Л.Ф., Николаева О.Г., Полонский В.О., Семененко Т.А. Состояние популяционного иммунитета в отношении инфекций, управляемых средствами специфической профилактики у медицинских работников (по материалам банка сывороток крови). Эпидемиология и инфекционные болезни. Актуальные вопросы. - 2016. - №3. - С.8-16. Gotvyanskaya T.P., Nozdracheva A.V., Rusakova E.V., Evseeva L.F., Nikolaeva O.G., Polonsky V.O., Semenenko T.A.Herd immunity against vaccine-preventable diseases among healthcare workers (according to serum bank materials). Epidemiology and infectious diseases. Current issues = Epidemiologiya i infektsionnyye bolezni. Aktual'nyye voprosy. 2016, №3, pp.8-16. (In Russ.)
  3. http://epidemiology-journal.ru
  4. Ерещенко А.А. Лабораторный мониторинг эффективности поствакцинального противокоревого иммунного ответа. // Медицинская иммунология, 2020. Т.22, №3. С. 563-568 Ereshchenko A.A. Laboratory monitoring of postvaccination Measles immunity. Medical Immunology (Russia)=Meditsinskaya Immunologiya, 2020, vol.22,no.3, pp. 563-568. (In Russ.) doi: 10.15789/1563-0625-LMO-1876
  5. Матиевская Н.В., Самойлович Е.О., Кузнецова Е.В., Васильев А.В., Семейко Г.В., Миклаш Л.В., Островская О.В. Клинико-эпидемиологические и диагностические особенности кори во время вспышки в вакцинированной популяции. Эпидемиология и инфекционные болезни. Актуальные вопросы. 2020. Т. 10. № 2. С. 25-31. Matievskaya N.V., Samoylovich E.O., Kuznetsova E.V., Vasiliev A.V., Semeyko G.V., Miklash L.V., Ostrovskaya O.V. Clinical, epidemiological and diagnostic features of measles during an outbreak in a vaccinated population. Epidemiology and infectious diseases. Current issues. = Epidemiologiya i infektsionnyye bolezni. Aktual'nyye voprosy. 2020. Vol. 10, No. 2, pp. 25-31. (In Russ.) doi: 10.18565/epidem.2020.10.2.25-31
  6. Ноздрачева А.В., Рыбин В.В., Грицик А.А., Заволожин В.А., Кузин С.Н., Семененко Т.А. Распространенность антител к вирусам кори, краснухи и эпидемическому паротиту у военнослужащих. Военно-медицинский журнал. - 2018. - Т. 339. №1. - С. 66-70 Nozdracheva A.V., Rybin V.V., Gritsik A.A., Zavolozhin V.A., Kuzin S.N., Semenenko T.A. Prevalence of antibody to measles, rubella, and epidemic parotitis in military personnel. Military medical journal. = Voyenno-meditsinskiy zhurnal,
  7. , vol. 339, №1., pp. 66-70 (In Russ.) http://sc.mil.ru:80/social/media/magazine/more.htm?id=8753@morfOrgInfo
  8. Топтыгина А.П. Общие закономерности формирования и поддержания специфического гуморального иммунного ответа на примере ответа на вирусы кори и краснухи. Инфекция и иммунитет. – 2014. - Т. 4, № 1. - С. 7-14. Toptygina A.P. Common mechanisms of specific humoral immune response’ shaping and sustaining by the example of immune response to measles and rubella viruses. Russian Journal of Infection and Immunity = Infektsiya i immunitet, 2014, vol. 4, no. 1, pp. 7-14. (In Russ.) doi: 10.15789/2220-7619-2014-1-7-14
  9. Топтыгина А.П., Андреев Ю.Ю., Смердова М.А., Наврузова Л.Н., Малеев В.В. Сопоставление гуморального иммунного ответа у взрослых, больных корью, и привитых от этой инфекции. Инфекция и иммунитет. – 2021. – Т.11,№3. – С. 517-522 Toptygina A.P., Andreev Yu.Yu., Smerdova M.A., Navruzova L.N., Maleev V.V. Comparing humoral immune response in adult measles patients and measles vaccinated subjects Russian Journal of Infection and Immunity = Infektsiya i immunitet, 2021, vol. 11, no. 3, pp. 517–522. (In Russ.) doi: 10.15789/2220-7619- CHI-1396
  10. Топтыгина А.П., Клыкова Т.Г., Смердова М.А., Зеткин А.Ю. Оценка напряженности популяционного иммунитета к вирусам кори, краснухи, эпидемического паротита и ветряной оспы у здоровых взрослых. РМЖ. – 2019. – Т.27, №3. – С.36-39. Toptygina A.P., Klykova T.G., Smerdova M.A., Zetkin A.Yu. Herd immunity to measles, rubella, mumps, and chickenpox in healthy adults. RMJ,2019, No3, pp.36–39. (In Russ.) ISSN 2225-2282
  11. Топтыгина А.П., Мамаева Т.А. Анализ особенностей иммунного ответа у взрослых, больных корью. Инфекция и иммунитет. – 2023. – Т.13,№4. – С. 691-698. Toptygina A.P., Mamaeva T.A. Analyzing features of measles immune response in adult patients Russian Journal of Infection and Immunity = Infektsiya i immunitet, 2023, vol. 13, no. 4, pp. 691–698. (In Russ.) doi: 10.15789/2220- 7619-AOM-13306
  12. Топтыгина А.П., Мамаева Т.А., Алешкин В.А. Особенности специфического гуморального иммунного ответа против вируса кори //Инфекция и иммунитет. 2013. Т.3 №3 С.243-250. Toptygina A.P., Mamaeva T.A., Alioshkin V.A. Peculiarities of specific humoral measles immune response Russian Journal of Infection and Immunity = Infektsiya i immunitet, 2013, Vol.3, no. 3, pp. 243-250. (In Russ.) https://www.elibrary.ru/item.asp?id=20350047
  13. Топтыгина А.П., Смердова М.А., Наумова М.А., Владимирова Н.П., Мамаева Т.А. Влияние особенностей популяционного иммунитета на структуру заболеваемости корью и краснухой // Инфекция и иммунитет. - 2018. - Т. 8, № 3. - С. 341–348. Toptygina A.P., Smerdova M.A., Naumova M.A., Vladimirova n.p., Mamaeva T.A. Influence of population immunity peculiarities on the structure of measles and rubella prevalence. Russian Journal of Infection and Immunity = Infektsiya i immunitet, 2018, Vol.8, no.3, pp.341-348. (In Russ.) doi: 10.15789/2220-7619-2018- 3-341-348
  14. Davidkin I., Jokinen S., Broman M., Leinikki P., Peltola H. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up. J Infect Dis., 2008, Vol.197(7), pp. 950-956. doi: 10.1086/528993
  15. Dixon MG, Ferrari M, Antoni S, Li X, Portnoy A, Lambert B, Hauryski S, Hatcher C, Nedelec Y, Patel M, Alexander JP Jr, Steulet C, Gacic-Dobo M, Rota PA, Mulders MN, Bose AS, Rosewell A, Kretsinger K, Crowcroft NS. Progress toward regional measles elimination—worldwide, 2000–2020. MMWR Morb Mortal Wkly Rep 2021, Vol.70(45), pp.1563–1569 doi: 10.15585/mmwr.mm7045a1
  16. Hanna-Wakima R., Yasukawa L. L., Sung P., Arvin A. M., Gans H. A. Immune Responses to Mumps Vaccine in Adults Who Were Vaccinated in Childhood. J Infect Dis., 2008, Vol. 197(12), pp. 1669–1675. doi: 10.1086/588195
  17. Kennedy R.B., Ovsyannikova I. G., Thomas A., Larrabee B. R., Rubin S., Poland G. A. Differential durability of immune responses to measles and mumps following MMR vaccination. Vaccine, 2019, Vol. 37 (13), pp. 1775–1784. doi: 10.1016/j.vaccine.2019.02.030
  18. Lignani L.K., de Vasconcellos Carvalhaes de Oliveira R., Dos Santos E. M., Bastos Camacho L. A., Xavier J.R., da Silva E. Sá G. R., Siqueira M. M., Vieira da Silva A. M., Melgaço J.G., Dos Santos Alves N., de Lourdes de Sousa Maia M., Prates Melo E. C. Neutralizing antibody titers against D8 genotype and persistence of measles humoral and cell-mediated immunity eight years after the first dose of measles, mumps, and rubella vaccine in Brazilian children. Vaccine, 2024, Vol. 42(8), pp.2065-2071. doi: 10.1016/j.vaccine.2024.02.060
  19. Makarenko C., Pedro A.S., Paiva N.S., dos Santos J.P.C., Medronho R. de A., Gibson G. Measles resurgence in Brazil: analysis of the 2019 epidemic in the state of São Paulo. Rev Saude Publica, 2022, Vol.13(56), pp.50. doi: 10.11606/s1518- 8787.2022056003805
  20. Seagle EE, Bednarczyk RA, Hill T, Fiebelkorn AP, Hickman CJ, Icenogle JP, Belongia EA, McLean HQ. Measles, mumps, and rubella antibody patterns of persistence and rate of decline following the second dose of the MMR vaccine. Vaccine 2018, Vol. 36(6), pp.818–826. doi: 10.1016/j.vaccine.2017.12.075
  21. Shepersky L., Marin M., Zhang J., Pham H., Marlow M.A. Mumps in Vaccinated Children and Adolescents: 2007-2019. Pediatrics, 2021, Vol. 148(6), e2021051873. doi: 10.1542/peds.2021-051873
  22. Wang L., Haralambieva I. H., Ovsyannikova I. G., Grill D. E., Warner N. D., Poland G. A., Kennedy R. B. Associations of adaptive immune cell subsets with measles, mumps, and Rubella− Specific immune response outcomes. Heliyon, 2023,Vol. 9, e22998. doi: 10.1016/j.heliyon.2023.e22998

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) Zherdeva P.E., Toptygina A.P., Nozdracheva A.V., Mamaeva T.A., Novikova L.I., Smerdova M.A., Iаrmolskaia M.S., Dementeva N.G., Gotvyanskay T.P., Semenenko A.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 64788 от 02.02.2016.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies